Additionally, Wang et al. designed a novel blood-brain barrier bypass strategy with glutathione (GSH)-responsive silica nanocapsules (SNCs) transport platform to optimize the delivery of CRISPR genome editors to different central nervous system genes such as amyloid precursor protein (App), the one involved in AD (59). Here, APP is linked to Alzheimer disease.